K.J. Harrison & Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.91M Buy
75,596
+62,000
+456% +$5M 0.84% 31
2026
Q1
$1.18M Buy
+13,596
New +$1.3M 0.19% 116
2025
Q4
Sell
-16,620
Closed -$1.59M 240
2025
Q3
$1.59M Buy
+16,620
New +$1.53M 0.23% 108
2024
Q1
Sell
-4,800
Closed -$395K 214
2023
Q4
$395K Buy
+4,800
New +$366K 0.07% 172
2023
Q3
Sell
-12,300
Closed -$1.08M 171
2023
Q2
$1.08M Buy
+12,300
New +$1.06M 0.2% 120
2023
Q1
Sell
-2,000
Closed -$211K 261
2022
Q4
$211K Buy
+2,000
New +$162K 0.04% 194
2022
Q1
Sell
-4,100
Closed -$425K 357
2021
Q4
$425K Buy
+4,100
New +$475K 0.06% 206
2020
Q4
Sell
-6,000
Closed -$624K 299
2020
Q3
$624K Buy
+6,000
New +$603K 0.13% 153

Other funds holding MDT

K.J. Harrison & Partners's MDT Position: Q2 2026 in Review

K.J. Harrison & Partners increased its Medtronic (MDT) stake by 456% in Q2 2026, buying an estimated $5M and bringing the position to 75,596 shares worth $5.91M. The position accounts for 0.84% of the portfolio, ranked #31.

K.J. Harrison & Partners first reported a position in MDT in Q3 2020 and has held it in 8 quarters since. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • K.J. Harrison & Partners held 75,596 shares of Medtronic worth $5.91M as of Q2 2026.
  • K.J. Harrison & Partners bought 62,000 Medtronic shares in Q2 2026, an estimated $5M.
  • Medtronic made up 0.84% of K.J. Harrison & Partners's portfolio in Q2 2026, its #31 holding.
  • K.J. Harrison & Partners first reported a position in Medtronic in Q3 2020 and has held it in 8 quarters since.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on K.J. Harrison & Partners's 13F filing for Q2 2026, filed 7 Aug 2026.